| Stage | ABNB | % of rev | EXPE | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $4.9B | 100.00% | $4.9B | 100.00% | EXPE ×1.01 |
| Gross profit | $4.2B | 86.63% | $4.9B | 100.00% | EXPE +13.4pp |
| Operating income | $2.0B | 41.51% | $1.3B | 26.85% | ABNB +14.7pp |
| Pre-tax income | $2.2B | 44.63% | $1.3B | 26.39% | ABNB +18.2pp |
| Net income | $1.9B | 38.82% | $1.0B | 21.04% | ABNB +17.8pp |
| Stage | ABNB | EXPE | Gap · A − B |
|---|---|---|---|
| Revenue | $4.9B100.00% | $4.9B100.00% | EXPE ×1.01 |
| Gross profit | 86.63%$4.2B | 100.00%$4.9B | EXPE +13.4pp |
| Operating income | 41.51%$2.0B | 26.85%$1.3B | ABNB +14.7pp |
| Pre-tax income | 44.63%$2.2B | 26.39%$1.3B | ABNB +18.2pp |
| Net income |
| 38.82%$1.9B |
| 21.04%$1.0B |
| ABNB +17.8pp |
None
No disclosed counterparties: ABNB.